Cargando…
Patients with B-cell lymphoma receiving anti-CD20 monoclonal antibody-containing chemotherapies and seroreactive patterns in response to COVID-19 vaccination
| Autores principales: | , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Springer Nature Singapore
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9004209/ https://www.ncbi.nlm.nih.gov/pubmed/35412265 http://dx.doi.org/10.1007/s12185-022-03349-1 |
| _version_ | 1784686240666222592 |
|---|---|
| author | Inaba, Tohru Okumura, Keita Maekura, Chika Muramatsu, Ayako Kobayashi, Tsutomu Kuroda, Junya Nukui, Yoko |
| author_facet | Inaba, Tohru Okumura, Keita Maekura, Chika Muramatsu, Ayako Kobayashi, Tsutomu Kuroda, Junya Nukui, Yoko |
| author_sort | Inaba, Tohru |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9004209 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | Springer Nature Singapore |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-90042092022-04-12 Patients with B-cell lymphoma receiving anti-CD20 monoclonal antibody-containing chemotherapies and seroreactive patterns in response to COVID-19 vaccination Inaba, Tohru Okumura, Keita Maekura, Chika Muramatsu, Ayako Kobayashi, Tsutomu Kuroda, Junya Nukui, Yoko Int J Hematol Letter to the Editor Springer Nature Singapore 2022-04-12 2022 /pmc/articles/PMC9004209/ /pubmed/35412265 http://dx.doi.org/10.1007/s12185-022-03349-1 Text en © Japanese Society of Hematology 2022 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic. |
| spellingShingle | Letter to the Editor Inaba, Tohru Okumura, Keita Maekura, Chika Muramatsu, Ayako Kobayashi, Tsutomu Kuroda, Junya Nukui, Yoko Patients with B-cell lymphoma receiving anti-CD20 monoclonal antibody-containing chemotherapies and seroreactive patterns in response to COVID-19 vaccination |
| title | Patients with B-cell lymphoma receiving anti-CD20 monoclonal antibody-containing chemotherapies and seroreactive patterns in response to COVID-19 vaccination |
| title_full | Patients with B-cell lymphoma receiving anti-CD20 monoclonal antibody-containing chemotherapies and seroreactive patterns in response to COVID-19 vaccination |
| title_fullStr | Patients with B-cell lymphoma receiving anti-CD20 monoclonal antibody-containing chemotherapies and seroreactive patterns in response to COVID-19 vaccination |
| title_full_unstemmed | Patients with B-cell lymphoma receiving anti-CD20 monoclonal antibody-containing chemotherapies and seroreactive patterns in response to COVID-19 vaccination |
| title_short | Patients with B-cell lymphoma receiving anti-CD20 monoclonal antibody-containing chemotherapies and seroreactive patterns in response to COVID-19 vaccination |
| title_sort | patients with b-cell lymphoma receiving anti-cd20 monoclonal antibody-containing chemotherapies and seroreactive patterns in response to covid-19 vaccination |
| topic | Letter to the Editor |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9004209/ https://www.ncbi.nlm.nih.gov/pubmed/35412265 http://dx.doi.org/10.1007/s12185-022-03349-1 |
| work_keys_str_mv | AT inabatohru patientswithbcelllymphomareceivinganticd20monoclonalantibodycontainingchemotherapiesandseroreactivepatternsinresponsetocovid19vaccination AT okumurakeita patientswithbcelllymphomareceivinganticd20monoclonalantibodycontainingchemotherapiesandseroreactivepatternsinresponsetocovid19vaccination AT maekurachika patientswithbcelllymphomareceivinganticd20monoclonalantibodycontainingchemotherapiesandseroreactivepatternsinresponsetocovid19vaccination AT muramatsuayako patientswithbcelllymphomareceivinganticd20monoclonalantibodycontainingchemotherapiesandseroreactivepatternsinresponsetocovid19vaccination AT kobayashitsutomu patientswithbcelllymphomareceivinganticd20monoclonalantibodycontainingchemotherapiesandseroreactivepatternsinresponsetocovid19vaccination AT kurodajunya patientswithbcelllymphomareceivinganticd20monoclonalantibodycontainingchemotherapiesandseroreactivepatternsinresponsetocovid19vaccination AT nukuiyoko patientswithbcelllymphomareceivinganticd20monoclonalantibodycontainingchemotherapiesandseroreactivepatternsinresponsetocovid19vaccination |